| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | Mirati Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | Mirati Therapeutics, Inc. | 4,886,840 | 7.0% | EDGAR |
| SC 13G/A | 2024-02-14 | ARMISTICE CAPITAL, LLC | Mirati Therapeutics, Inc. | 500,000 | 0.7% | EDGAR |
| SC 13G | 2024-02-14 | BAKER BROS. ADVISORS LP | Mirati Therapeutics, Inc. | - | 0.0% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Mirati Therapeutics, Inc. | 5,306,693 | 7.6% | EDGAR |
| SC 13G/A | 2024-02-09 | MORGAN STANLEY | Mirati Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2024-02-09 | MORGAN STANLEY | Mirati Therapeutics, Inc. | 6,079,302 | 8.7% | EDGAR |
| SC 13G/A | 2024-02-08 | WELLINGTON MANAGEMENT GROUP LLP | Mirati Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2024-01-31 | BlackRock Inc. | Mirati Therapeutics, Inc. | 3,866,202 | 5.5% | EDGAR |
| SC 13D/A | 2024-01-25 | Boxer Capital, LLC | Mirati Therapeutics, Inc. | - | 0.0% | EDGAR |
| SC 13G/A | 2023-12-27 | EcoR1 Capital, LLC | Mirati Therapeutics, Inc. | 7,396,979 | 10.5% | EDGAR |
| SC 13D/A | 2023-10-12 | Boxer Capital, LLC | Mirati Therapeutics, Inc. | 3,534,249 | 4.8% | EDGAR |
| SC 13G | 2023-10-02 | EcoR1 Capital, LLC | Mirati Therapeutics, Inc. | 5,748,399 | 8.5% | EDGAR |
| SC 13D/A | 2023-08-16 | Boxer Capital, LLC | Mirati Therapeutics, Inc. | 3,534,249 | 4.8% | EDGAR |
| SC 13G/A | 2023-02-14 | Avoro Capital Advisors LLC | Mirati Therapeutics, Inc. | 5,555,555 | 9.6% | EDGAR |
| SC 13G/A | 2023-02-14 | PERCEPTIVE ADVISORS LLC | Mirati Therapeutics, Inc. | 2,191,425 | 3.8% | EDGAR |
| SC 13G | 2023-02-14 | RTW INVESTMENTS, LP | Mirati Therapeutics, Inc. | 3,643,114 | 6.3% | EDGAR |
| SC 13G | 2023-02-14 | ARMISTICE CAPITAL, LLC | Mirati Therapeutics, Inc. | 3,488,000 | 6.1% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Mirati Therapeutics, Inc. | 4,973,888 | 8.6% | EDGAR |
| SC 13G/A | 2023-02-06 | WELLINGTON MANAGEMENT GROUP LLP | Mirati Therapeutics, Inc. | 3,016,335 | 5.2% | EDGAR |